Open Access Green as soon as Postprint is submitted to ZB.
Antifolate effect of triamterene on human leucocytes and on a human lymphoma cell line.
Eur. J. Clin. Pharmacol. 20, 219-224 (1981)
The inhibitory effect of triamterene and its metabolites on human leucocyte dihydrofolate reductase has been studied. Under test conditions with dihydrofolic acid 0.5×10-5 M, triamterene 7×10-5 M produced total enzyme inhibition, whereas the metabolites hydroxytriamterene and the sulphate ester of hydroxytriamterene were less effective inhibitors; at their maximum attainable concentration of 5×10-5 M, dihydrofolate reductase was inhibited by 80% and 50%, respectively. Cultures of the BJAB-B95-8 human lymphoma cell line were incubated with various concentrations of triamterene. Because of their increased specific activity of dihydrofolate reductase, the cells were able to maintain normal DNA metabolism, as measured by the ratio of the incorporation rates of 3H-deoxyuridine and 3H-thymidine, as well as normal cell growth at 1×10-6 M, and in some cases at 1 × 10-5 M triamterene. At 8×10-5 M triamterene, the strong inhibitory effect caused severe impairment of DNA metabolism and subsequently dissolution of the cell culture. The results are discussed in relation to the possible toxic side effects of long-term triamterene treatment in patients suffering from alcoholic cirrhosis, who may have impaired metabolism of triamterene and a concomitant severe folate deficiency.
Impact Factor
Scopus SNIP
Scopus
Cited By
Cited By
Altmetric
0.000
0.000
8
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Bjab-b95-8 ; Dihydrofolate Reductase ; Dna Metabolism ; Folate Antagonism ; Human Leucocytes ; Lymphoma Cell Line ; Triamterene ; Triamterene Metabolites
Language
english
Publication Year
1981
HGF-reported in Year
0
ISSN (print) / ISBN
0031-6970
e-ISSN
1432-1041
Quellenangaben
Volume: 20,
Issue: 3,
Pages: 219-224
Publisher
Springer
Reviewing status
Peer reviewed
Institute(s)
Institut für Hämatologie
PubMed ID
7286039
Scopus ID
0019445582
Erfassungsdatum
1981-05-30